Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;104(8):789-792.
doi: 10.1136/archdischild-2018-315617. Epub 2019 Apr 20.

Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review

Affiliations
Review

Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review

Jascha Kehr et al. Arch Dis Child. 2019 Aug.

Abstract

Objective: Guidelines state that verapamil is contraindicated in infants. This is based on reports of cardiovascular collapse and even death after rapid intravenous administration of verapamil in infants with supraventricular tachycardia (SVT). We wish to challenge this contraindication for the specific indication of verapamil sensitive ventricular tachycardia (VSVT) in infants.

Design: Retrospective case series and critical literature review.

Setting: Hospitals within New Zealand.

Patients: We present a series of three infants/young children with VSVT or 'fascicular VT'.

Results: Three children aged between 8 days and 2 years presented with tachycardia 200-220 beats per minute with right bundle brunch block and superior axis. Adenosine failed to cardiovert and specialist review diagnosed VSVT. There were no features of cardiovascular shock. Verapamil was given as a slow infusion over 10-30 min (rather than as a push) and each successfully cardioverted without incident. Critical review of the literature reveals that cardiovascular collapses were associated with a rapid intravenous push in cardiovascularly compromised infants and/or infants given other long-acting antiarrhythmics prior to verapamil.

Conclusions: Verapamil is specifically indicated for the treatment of fascicular VT, and for this indication should be used in infancy, as well as in older children, as first-line treatment or after failure of adenosine raises suspicion of the diagnosis. We outline how to distinguish this tachycardia from SVT and propose a strategy for the safe intravenous slow infusion of verapamil in children, noting that extreme caution is necessary with pre-existing ventricular dysfunction.

Keywords: ECG; arrhythmia; calcium channel blocker; contraindication; infant; safety; ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A) ECG of patient 1 on arrival. This shows a tachycardia at about 220 bpm with a superior axis and right bundle branch block. There are no capture beats but ventriculoatrial (VA) dissociation is visible, proving this to be ventricular tachycardia (VT) and not supraventricular tachycardia (SVT) with aberrancy. Superior axis and right bundle branch block (RBBB) make this the most common form of fascicular VT; left posterior fascicular VT. (B) ECG after conversion to sinus rhythm with intravenous verapamil. This shows a normal axis and no fascicular block. This indicates involvement of the posterior fascicle as retrograde limb in the tachycardia circuit.
Figure 2
Figure 2
(A) ECG on presentation in the 2-year-old child. It demonstrates tachycardia at 194 bpm with right bundle branch block (RBBB) and superior axis deviation. (B) Three-lead rhythm strip from case 3: this demonstrates ventriculoatrial (VA) dissociation and capture beats proving that this is ventricular tachycardia. Green arrows mark P waves and red arrows mark capture beats.

Similar articles

Cited by

References

    1. Wetzel GT, Chen F, Klitzner TS. L- and T-type calcium channels in acutely isolated neonatal and adult cardiac myocytes. Pediatr Res 1991;30:89–94. 10.1203/00006450-199107000-00018 - DOI - PubMed
    1. Wetzel GT, Klitzner TS. Developmental cardiac electrophysiology recent advances in cellular physiology. Cardiovasc Res 1996;31(Spec No):E52–60. 10.1016/S0008-6363(95)00158-1 - DOI - PubMed
    1. Gibson R, Driscoll D, Gillette P, et al. . The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs. Dev Pharmacol Ther 1981;2:104–16. 10.1159/000481036 - DOI - PubMed
    1. Epstein ML, Kiel EA, Victorica BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 1985;75:737–40. - PubMed
    1. Radford D. Side effects of verapamil in infants. Arch Dis Child 1983;58:465–6. 10.1136/adc.58.6.465 - DOI - PMC - PubMed